Dashboard
Manage Tickers

ENVBEnveric Biosciences, Inc.

Nasdaq enveric.com


$ 0.79 $ -0.03 (-3.96 %)    

Wednesday, 15-May-2024 13:33:42 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 452.83 $ 6.97 (1.56 %)
DIA $ 399.31 $ 3.70 (0.94 %)
SPY $ 529.09 $ 6.48 (1.24 %)
TLT $ 92.14 $ 1.24 (1.36 %)
GLD $ 220.89 $ 2.80 (1.28 %)
$ 0.788
$ 0.79
$ 0.00 x 0
$ 0.00 x 0
$ 0.79 - $ 0.79
$ 0.65 - $ 6.98
179,376
na
3.15M
$ 1.51
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-15-2024 03-31-2024 10-Q
2 03-26-2024 12-31-2023 10-K
3 11-13-2023 09-30-2023 10-Q
4 08-11-2023 06-30-2023 10-Q
5 05-15-2023 03-31-2023 10-Q
6 03-31-2023 12-31-2022 10-K
7 11-14-2022 09-30-2022 10-Q
8 08-12-2022 06-30-2022 10-Q
9 05-13-2022 03-31-2022 10-Q
10 03-31-2022 12-31-2021 10-K
11 11-13-2021 09-30-2021 10-Q
12 08-13-2021 06-30-2021 10-Q
13 05-17-2021 03-31-2021 10-Q
14 04-01-2021 12-31-2020 10-K
15 11-16-2020 09-30-2020 10-Q
16 08-14-2020 06-30-2020 10-Q
17 05-15-2020 03-31-2020 10-Q
18 03-25-2020 12-31-2019 10-K
19 11-08-2019 09-30-2019 10-Q
20 08-14-2019 06-30-2019 10-Q
21 05-14-2019 03-31-2019 10-Q
22 03-26-2019 12-31-2018 10-K
23 11-14-2018 09-30-2018 10-Q
24 08-14-2018 06-30-2018 10-Q
25 05-15-2018 03-31-2018 10-Q
26 04-02-2018 12-31-2017 10-K
27 11-13-2017 09-30-2017 10-Q
28 08-14-2017 06-30-2017 10-Q
29 05-12-2017 03-31-2017 10-Q
30 03-31-2017 12-31-2016 10-K
31 11-14-2016 09-30-2016 10-Q
32 08-12-2016 06-30-2016 10-Q
33 05-16-2016 03-31-2016 10-Q
34 11-23-2015 09-30-2015 10-Q
35 08-14-2015 06-30-2015 10-Q
36 05-14-2015 03-31-2015 10-Q
37 03-31-2015 12-31-2014 10-K
38 11-13-2014 09-30-2014 10-Q
39 08-11-2014 06-30-2014 10-Q
40 05-07-2014 03-31-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

enveric-biosciences-q1-2024-gaap-eps-061-beats-078-estimate
Enveric Biosciences Q1 2024 GAAP EPS $(0.6...
05/15/2024 10:11:36

Enveric Biosciences (NASDAQ:ENVB) reported quarterly losses of $(0.61) per share which beat the analyst consensus estimate of $...

microdosing-for-depression-psychedelics-biotech-signs-665m-non-binding-deal-to-out-license-novel-psilocin-prodrug-candidate
Microdosing For Depression: Psychedelics B...
05/14/2024 12:00:58

12-health-care-stocks-moving-in-wednesdays-pre-market-session
12 Health Care Stocks Moving In Wednesday'...
05/08/2024 12:06:34

cannabinoids-with-chemotherapy-for-breast-cancer-psychedelics-biotech-inks-61m-license-deal-for-patented-methods
Cannabinoids With Chemotherapy For Breast ...
05/08/2024 11:05:57

The news of the licensee deal comes on the heels of the DEA's move to reschedule marijuana, one source of cannabinoids, as ...

Core News & Articles
"FDA Expert Committee Will Review MDMA-Ass...
05/07/2024 15:54:11

https://www.marijuanamoment.net/fda-expert-committee-will-review-mdma-assisted-therapy-for-ptsd-next-month/The Food and Drug Ad...

psyched-dea-revisits-ban-on-two-psychedelics-farewell-russell-newcombe-podcast-episode-on-kanna--more
Psyched: DEA Revisits Ban On Two Psychedel...
04/17/2024 12:42:33

why-ulta-beauty-shares-are-trading-lower-by-around-14-here-are-other-stocks-moving-in-wednesdays-mid-day-session
Why Ulta Beauty Shares Are Trading Lower B...
04/03/2024 17:56:10

Shares of Ulta Beauty, Inc. (NASDAQ: ULTA) fell sharply during Wednesday’s session amid the company's presentation at the ...

12-health-care-stocks-moving-in-wednesdays-pre-market-session
12 Health Care Stocks Moving In Wednesday'...
04/03/2024 12:09:46

12-health-care-stocks-moving-in-tuesdays-after-market-session
12 Health Care Stocks Moving In Tuesday's ...
04/02/2024 20:31:04

psyched-5-meo-dmt-for-depression-utah-hospitals-providing-therapy-elon-musk-and-metas-influence
Psyched: 5-MeO-DMT For Depression, Utah Ho...
03/29/2024 16:43:17

enveric-biosciences-optimistic-on-q4-and-full-year-results-psychedelic-inspired-meds-for-future-growth
Enveric Biosciences Optimistic On Q4 And F...
03/27/2024 12:59:52

psyched-lsd-psilocybin-as-breakthrough-therapies-14m-fed-grant-for-ibogaine-indianas-research-and-more
Psyched: LSD, Psilocybin As Breakthrough T...
03/20/2024 18:49:36

12-health-care-stocks-moving-in-tuesdays-after-market-session
12 Health Care Stocks Moving In Tuesday's ...
03/19/2024 21:34:06

enveric-biosciences-canada-granted-us-patent-11931338-nitrilated-psilocybin-derivatives-and-methods-of-using
Enveric Biosciences Canada Granted U.S. Pa...
03/19/2024 19:31:05

https://ppubs.uspto.gov/dirsearch-public/print/downloadPdf/11931338

why-peraso-shares-are-trading-lower-by-over-23-here-are-other-stocks-moving-in-tuesdays-mid-day-session
Why Peraso Shares Are Trading Lower By Ove...
03/19/2024 17:48:27

Shares of Peraso Inc. (NASDAQ: PRSO) fell sharply during Tuesday’s session after the company reported worse-than-expected four...

nasdaq-down-100-points-us-housing-starts-surge-in-february
Nasdaq Down 100 Points; US Housing Starts ...
03/19/2024 13:40:27

U.S. stocks traded mixed this morning, with the Nasdaq Composite falling around 100 points on Tuesday. Following the market op...

why-is-anxietyaddiction-focused-enveric-biosciences-stock-trading-higher-tuesday
Why Is Anxiety/Addiction-Focused Enveric B...
03/19/2024 13:34:56

Enveric Biosciences announces significant progress with non-binding term sheets signed with a biotech firm for cannabinoid-COX-...

12-health-care-stocks-moving-in-tuesdays-pre-market-session
12 Health Care Stocks Moving In Tuesday's ...
03/19/2024 13:05:53

the-non-pharmaceutical-application-term-sheet-provides-that-enveric-could-be-eligible-to-receive-future-development-and-sales-milestone-payments-of-up-to-approximately-21m-and-with-royalty-rates-ranging-from-025-up-to-7
The Non-pharmaceutical Application Term Sh...
03/19/2024 11:09:42

the-pharmaceutical-application-term-sheet-provides-enveric-biosciences-could-be-eligible-to-receive-future-development-and-sales-milestone-payments-that-in-total-could-add-up-to-approximately-61m
The Pharmaceutical Application Term Sheet ...
03/19/2024 11:08:09

Royalty rates could range from 2.5% up to 10% on future sales, depending on meeting certain sales criteria.

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION